Patents by Inventor Kenneth Hess

Kenneth Hess has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Gene sets for glioma classification
    Patent number: 7341552
    Abstract: The present invention provides a number of gene markers whose expression is altered in various gliomas. In particular, by examining the expression these markers, one can accurately classify a glioma as glioblastoma multiforme (GM), anaplastic astrocytoma (AA), anaplastic oligodendroglioma (AO) or oligodendroglioma (OL). The diagnosis may be performed on nucleic acids, for example, using a DNA microarray, or on protein, for example, using immunologic means. Also disclosed are methods of therapy.
    Type: Grant
    Filed: March 17, 2003
    Date of Patent: March 11, 2008
    Assignees: The University of Texas System Board of Regents, The Texas A & M University System
    Inventors: Wei Zhang, Greg Fuller, Ed Dougherty, Kenneth Hess
  • Multigene predictors of response to chemotherapy
    Publication number: 20050266420
    Abstract: The present invention provides the identification of genes that are expressed in tumors that are responsive to a given therapeutic agent and whose expression (either increased expression or decreased expression) correlates with responsiveness to that therapeutic agent. One or more of the genes of the present invention can be used as markers (or surrogate markers) to identify tumors that are likely to be successfully treated by that agent.
    Type: Application
    Filed: September 30, 2004
    Publication date: December 1, 2005
    Inventors: Lajos Pusztai, W. Symmans, Kenneth Hess, Mark Ayers, James Stec
  • Strong gene sets for glioma classification
    Publication number: 20040053277
    Abstract: The present invention provides a number of gene markers whose expression is altered in various gliomas. In particular, by examining the expression these markers, one can accurately classify a glioma as glioblastoma multiforme (GM), anaplastic astrocytoma (AA), anaplastic oligodendroglioma (AO) or oligodendroglioma (OL). The diagnosis may be performed on nucleic acids, for example, using a DNA microarray, or on protein, for example, using immunologic means. Also disclosed are methods of therapy.
    Type: Application
    Filed: March 17, 2003
    Publication date: March 18, 2004
    Applicants: Board of Regents, The University of Texas System, The Texas A&M University System
    Inventors: Wei Zhang, Greg Fuller, Ed Dougherty, Kenneth Hess